Net Worth Advisory Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.09M Sell
12,181
-1,831
-13% -$427K 0.78% 20
2026
Q1
$3.43M Sell
14,012
-545
-4% -$127K 0.71% 26
2025
Q4
$3.01M Buy
14,557
+2,820
+24% +$558K 0.61% 33
2025
Q3
$2.18M Sell
11,737
-2,077
-15% -$356K 0.63% 29
2025
Q2
$2.11M Buy
13,814
+2,614
+23% +$402K 0.47% 45
2025
Q1
$1.86M Buy
11,200
+608
+6% +$95.1K 0.58% 27
2024
Q4
$1.53M Sell
10,592
-824
-7% -$128K 0.47% 37
2024
Q3
$1.85M Buy
+11,416
New +$1.82M 0.55% 31

Other funds holding JNJ

Net Worth Advisory Group's JNJ Position: Q2 2026 in Review

Net Worth Advisory Group reduced its Johnson & Johnson (JNJ) stake by 13% in Q2 2026, selling an estimated $427K and leaving 12,181 shares worth $3.09M. The position accounts for 0.78% of the portfolio, ranked #20.

Net Worth Advisory Group first reported a position in JNJ in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.43M in Q1 2026. 984 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Net Worth Advisory Group held 12,181 shares of Johnson & Johnson worth $3.09M as of Q2 2026.
  • Net Worth Advisory Group sold 1,831 Johnson & Johnson shares in Q2 2026, an estimated $427K.
  • Johnson & Johnson made up 0.78% of Net Worth Advisory Group's portfolio in Q2 2026, its #20 holding.
  • Net Worth Advisory Group first reported a position in Johnson & Johnson in Q3 2024 and has held it in 8 quarters since.
  • Net Worth Advisory Group's Johnson & Johnson position peaked at $3.43M in Q1 2026.
  • 984 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Net Worth Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.